Demand for FDA Action Amid Shuffle

Demand for FDA Action Amid Shuffle

Demand for FDA Action Amid Shuffle Sarah Owermohle, Zachary Brennan and David Lim | Politico “The president’s executive order for CMS to finalize a rule eliminating rebates that drugmakers pay to pharmacy benefit managers had one big caveat — the rule cannot...
Shared Savings Models Could Yield Part B Savings

Shared Savings Models Could Yield Part B Savings

Shared Savings Models Could Yield Part B Savings Skylar Jeremias | The Center for Biosimilars “The establishment of a shared savings model has the potential to increase health care savings, biologic competition, and biosimilar utilization if implemented in...